Regulatory News:
Transgene (Paris:TNG) (NYSE-Euronext: TNG) today announced the appointment of Eric Quéméneur, PhD as Executive Vice President in charge of Research and Development. In this position, he will lead all of the Company’s research activities, from discovery through pre-clinical. Dr. Quéméneur is a member of Transgene’s Management Committee.
Help employers find you! Check out all the jobs and post your resume.
